Your browser doesn't support javascript.
loading
Psychiatric comorbidities among COVID-19 survivors in North India: A cross-sectional study.
Dar, Shabir Ahmad; Dar, Mohammad Maqbool; Sheikh, Shanoo; Haq, Inaamul; Azad, Aaliya Mohi Ud Din; Mushtaq, Mehvish; Shah, Naveed Nazir; Wani, Zaid Ahmad.
Afiliação
  • Dar SA; Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.
  • Dar MM; Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.
  • Sheikh S; Department of Clinical Psychology, College of Health and Rehabilitation, Princess Nourah Abdulrahman University, Riyadh, Saudi Arabia.
  • Haq I; Department of Social and Preventive Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India.
  • Azad AMUD; Department of Respiratory Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India.
  • Mushtaq M; Department of Respiratory Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India.
  • Shah NN; Department of Respiratory Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India.
  • Wani ZA; Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India.
J Educ Health Promot ; 10: 309, 2021.
Article em En | MEDLINE | ID: mdl-34667809
ABSTRACT

BACKGROUND:

The coronavirus disease-19 (COVID-19) emerged from China and rapidly spread to many other countries all over the world. This study aimed to assess the prevalence of anxiety, depression, posttraumatic stress disorder, and obsessive-compulsive (OC) symptoms among COVID-19 survivors after their discharge from the COVID-19 treatment center. MATERIALS AND

METHODS:

This was a cross-sectional, hospital-based study performed among 119 COVID-19 survivors. The Hospital Anxiety and Depression Scale (HADS) was used to measure anxiety and depression. Posttraumatic Stress Disorder (PTSD)-Checklist (PCL) and Brief OC Scale were used to measure PTSD and OC symptoms. Data were analyzed by descriptive and inferential statistics using the SPSS (IBM Corp. Released 2015 version 23.0).

RESULTS:

The mean anxiety, depression, and PTSD scores were, 7.12 ± 0.68, 8.08 ± 0.22, and 19.78 ± 0.88, respectively. Based on cutoff scores, the prevalence of anxiety, depression, and PTSD among COVID-19 survivors was n = 53, 44.54%; n = 73, 61.34%; and n = 30, 25.21%, respectively. Older COVID-19 survivors (≥50 years) were more likely to show symptoms of depression and anxiety (P < 0.001) compared to younger ones. Furthermore, COVID-19 survivors who were ≥50 years of age experienced a greater level of PTSD compared to younger ones; similar trends were seen in those experiencing OC symptoms. In the present study, n = 98 (82.4%) were obsessed with fears of contamination and an equal number had compulsive handwashing.

CONCLUSION:

Anxiety, depression, PTSD, and OC symptoms are common among the COVID-19 survivors and that underscores the need to diagnose and manage mental health morbidities among these survivors long after their recovery from COVID-19.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article